Otonomy has announced the publication of the positive results of the Phase III clinical trials of Otiprio (ciprofloxacin otic suspension)...
Otonomy has announced that the FDA has approved Otiprio (ciprofloxacin otic suspension) for the treatment of paediatric patients with bilateral...